ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CPH Cipher Pharmaceuticals Inc

8.69
-0.13 (-1.47%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cipher Pharmaceuticals Inc TSX:CPH Toronto Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.13 -1.47% 8.69 8.64 8.70 8.81 8.59 8.79 21,454 22:00:00

Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call

04/05/2023 10:00pm

PR Newswire (Canada)


Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Cipher Pharmaceuticals Charts.

MISSISSAUGA, ON, May 4, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the first quarter of 2023 on Thursday, May 11, 2023. The Company will also host a conference call on Friday, May 12, 2023 at 8:30am ET to discuss the results and corporate developments. 

CONFERENCE CALL DETAILS

DATE:                                    Friday, May 12, 2023
TIME:                                     8:30 a.m. EDT
DIAL-IN NUMBER:                (416) 764-8650 or (888) 664-6383
CONFERENCE ID:                40452017
REPLAY DIAL-IN:                  (888) 390-0541 (playback 452017#)
                                               Expires May 19, 2022
WEBCAST:                             https://app.webinar.net/wOPDyeLaKb0

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Copyright 2023 Canada NewsWire

1 Year Cipher Pharmaceuticals Chart

1 Year Cipher Pharmaceuticals Chart

1 Month Cipher Pharmaceuticals Chart

1 Month Cipher Pharmaceuticals Chart